189 related articles for article (PubMed ID: 34582036)
21. Malignant Neoplasms of the Gastrointestinal Tract After Blood or Marrow Transplant.
McDonald A; Dai C; Meng Q; Hageman L; Richman J; Wu J; Francisco L; Ross E; Balas N; Bosworth A; Te HS; Wong FL; Landier W; Salzman D; Bhatia R; Weisdorf DJ; Forman SJ; Armenian SH; Bhatia S
JAMA Oncol; 2023 Mar; 9(3):376-385. PubMed ID: 36656600
[TBL] [Abstract][Full Text] [Related]
22. Risk of second malignant neoplasms after childhood central nervous system malignant tumours: an international study.
Maule M; Scélo G; Pastore G; Brennan P; Hemminki K; Pukkala E; Weiderpass E; Olsen JH; Tracey E; McBride ML; Brewster DH; Pompe-Kirn V; Tonita JM; Kliewer EV; Chia KS; Jonasson JG; Martos C; Magnani C; Boffetta P
Eur J Cancer; 2008 Apr; 44(6):830-9. PubMed ID: 18329873
[TBL] [Abstract][Full Text] [Related]
23. Total body irradiation dose and risk of subsequent neoplasms following allogeneic hematopoietic cell transplantation.
Baker KS; Leisenring WM; Goodman PJ; Ermoian RP; Flowers ME; Schoch G; Storb R; Sandmaier BM; Deeg HJ
Blood; 2019 Jun; 133(26):2790-2799. PubMed ID: 30992266
[TBL] [Abstract][Full Text] [Related]
24. Risks of subsequent primary cancers among breast cancer survivors according to hormone receptor status.
Sung H; Freedman RA; Siegel RL; Hyun N; DeSantis CE; Ruddy KJ; Jemal A
Cancer; 2021 Sep; 127(18):3310-3324. PubMed ID: 34002851
[TBL] [Abstract][Full Text] [Related]
25. Second malignancies after autologous hematopoietic cell transplantation in children.
Danner-Koptik KE; Majhail NS; Brazauskas R; Wang Z; Buchbinder D; Cahn JY; Dilley KJ; Frangoul HA; Gross TG; Hale GA; Hayashi RJ; Hijiya N; Kamble RT; Lazarus HM; Marks DI; Reddy V; Savani BN; Warwick AB; Wingard JR; Wood WA; Sorror ML; Jacobsohn DA
Bone Marrow Transplant; 2013 Mar; 48(3):363-8. PubMed ID: 22964594
[TBL] [Abstract][Full Text] [Related]
26. Long-term risk of subsequent cancer incidence among hereditary and nonhereditary retinoblastoma survivors.
Schonfeld SJ; Kleinerman RA; Abramson DH; Seddon JM; Tucker MA; Morton LM
Br J Cancer; 2021 Mar; 124(7):1312-1319. PubMed ID: 33473166
[TBL] [Abstract][Full Text] [Related]
27. Treatment-specific risks of second malignancies and cardiovascular disease in 5-year survivors of testicular cancer.
van den Belt-Dusebout AW; de Wit R; Gietema JA; Horenblas S; Louwman MW; Ribot JG; Hoekstra HJ; Ouwens GM; Aleman BM; van Leeuwen FE
J Clin Oncol; 2007 Oct; 25(28):4370-8. PubMed ID: 17906202
[TBL] [Abstract][Full Text] [Related]
28. Risk of solid subsequent malignant neoplasms after childhood Hodgkin lymphoma-Identification of high-risk populations to guide surveillance: A report from the Late Effects Study Group.
Holmqvist AS; Chen Y; Berano Teh J; Sun C; Birch JM; van den Bos C; Diller LR; Dilley K; Ginsberg J; Martin LT; Nagarajan R; Nathan PC; Neglia JP; Terenziani M; Tishler D; Meadows AT; Robison LL; Oberlin O; Bhatia S
Cancer; 2019 Apr; 125(8):1373-1383. PubMed ID: 30556153
[TBL] [Abstract][Full Text] [Related]
29. Elevated Risk of Radiation Therapy-Associated Second Malignant Neoplasms in Young African-American Women Survivors of Stage I-IIIA Breast Cancer.
Xie L; Bao X; Cai T; Silva SG; Ma J; Zhang Z; Guo X; Marks LB
Int J Radiat Oncol Biol Phys; 2019 Oct; 105(2):275-284. PubMed ID: 31201893
[TBL] [Abstract][Full Text] [Related]
30. Identification of risk factors and prediction models for secondary malignant neoplasms (SMNs)-free survival and SMNs-specific survival in testicular cancer survivors.
Fu H; Talluri S; Rai S; Liang L; Trivedi J; Ankem MK
World J Urol; 2023 Sep; 41(9):2413-2420. PubMed ID: 37530808
[TBL] [Abstract][Full Text] [Related]
31. Second malignant neoplasms among children, adolescents and young adults with Wilms tumor.
Lee JS; Padilla B; DuBois SG; Oates A; Boscardin J; Goldsby RE
Pediatr Blood Cancer; 2015 Jul; 62(7):1259-64. PubMed ID: 25809878
[TBL] [Abstract][Full Text] [Related]
32. Risk of Soft-Tissue Sarcoma Among 69 460 Five-Year Survivors of Childhood Cancer in Europe.
Bright CJ; Hawkins MM; Winter DL; Alessi D; Allodji RS; Bagnasco F; Bárdi E; Bautz A; Byrne J; Feijen EAM; Fidler MM; Garwicz S; Grabow D; Gudmundsdottir T; Guha J; Haddy N; Jankovic M; Kaatsch P; Kaiser M; Kuehni CE; Linge H; Øfstaas H; Ronckers CM; Skinner R; Teepen JC; Terenziani M; Vu-Bezin G; Wesenberg F; Wiebe T; Sacerdote C; Jakab Z; Haupt R; Lähteenmäki P; Zaletel LZ; Kuonen R; Winther JF; de Vathaire F; Kremer LC; Hjorth L; Reulen RC;
J Natl Cancer Inst; 2018 Jun; 110(6):649-660. PubMed ID: 29165710
[TBL] [Abstract][Full Text] [Related]
33. Risk of second malignancies in survivors of retinoblastoma: more than 40 years of follow-up.
Marees T; Moll AC; Imhof SM; de Boer MR; Ringens PJ; van Leeuwen FE
J Natl Cancer Inst; 2008 Dec; 100(24):1771-9. PubMed ID: 19066271
[TBL] [Abstract][Full Text] [Related]
34. Risk of a second malignant neoplasm among 5-year survivors of cancer in childhood and adolescence in British Columbia, Canada.
MacArthur AC; Spinelli JJ; Rogers PC; Goddard KJ; Phillips N; McBride ML
Pediatr Blood Cancer; 2007 Apr; 48(4):453-9. PubMed ID: 16767718
[TBL] [Abstract][Full Text] [Related]
35. Premature ovarian insufficiency in female adolescent and young adult survivors of non-gynecological cancers: a population-based cohort study.
Flatt SB; Baillargeon A; McClintock C; Pudwell J; Velez MP
Reprod Health; 2023 Jan; 20(1):4. PubMed ID: 36593491
[TBL] [Abstract][Full Text] [Related]
36. Secondary malignant neoplasms after bone and soft tissue sarcomas in children, adolescents, and young adults.
Kube SJ; Blattmann C; Bielack SS; Kager L; Kaatsch P; Kühne T; Sorg B; Kevric M; Jabar S; Hallmen E; Sparber-Sauer M; Klingebiel T; Koscielniak E; Dirksen U; Hecker-Nolting S; Gerß JWO
Cancer; 2022 May; 128(9):1787-1800. PubMed ID: 35195899
[TBL] [Abstract][Full Text] [Related]
37. Subsequent Primary Cancer Risk Among 5-Year Survivors of Adolescent and Young Adult Cancers.
Sung H; Siegel RL; Hyun N; Miller KD; Yabroff KR; Jemal A
J Natl Cancer Inst; 2022 Aug; 114(8):1095-1108. PubMed ID: 35511931
[TBL] [Abstract][Full Text] [Related]
38. Second neoplasms in survivors of childhood cancer: findings from the Childhood Cancer Survivor Study cohort.
Meadows AT; Friedman DL; Neglia JP; Mertens AC; Donaldson SS; Stovall M; Hammond S; Yasui Y; Inskip PD
J Clin Oncol; 2009 May; 27(14):2356-62. PubMed ID: 19255307
[TBL] [Abstract][Full Text] [Related]
39. Cumulative burden of subsequent neoplasms, cardiovascular and respiratory morbidity in young people surviving cancer.
Smith L; Glaser AW; Greenwood DC; Feltbower RG
Cancer Epidemiol; 2020 Jun; 66():101711. PubMed ID: 32279022
[TBL] [Abstract][Full Text] [Related]
40. Risk of second malignant neoplasms in women and girls with germ cell tumors.
Liao Z; Rodrigues MC; Poynter JN; Amatruda JF; Rodriguez-Galindo C; Frazier AL
Ann Oncol; 2017 Feb; 28(2):329-332. PubMed ID: 27864217
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
